CYP2B6 516GT+TT combined genotype revealed a risk for acquisition of ARV‐associated hepatotoxicity and its severity in combined alcohol and nevirapine users (OR = 1.67, p = 0.37; OR = 4.00, p = 0.46, respectively). This evidence concerns the gene CYP2B6 and hepatotoxicity.